Algert Global LLC Kiniksa Pharmaceuticals, Ltd. Transaction History
Algert Global LLC
- $2.55 Billion
- Q1 2024
A detailed history of Algert Global LLC transactions in Kiniksa Pharmaceuticals, Ltd. stock. As of the latest transaction made, Algert Global LLC holds 10,447 shares of KNSA stock, worth $199,537. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,447Holding current value
$199,537% of portfolio
0.01%Shares
7 transactions
Others Institutions Holding KNSA
# of Institutions
164Shares Held
40.6MCall Options Held
186KPut Options Held
157K-
Black Rock Inc. New York, NY4.19MShares$80.1 Million0.0% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.2MShares$61.2 Million10.07% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E93.14MShares$59.9 Million1.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.98MShares$57 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY2.81MShares$53.7 Million0.7% of portfolio
About Kiniksa Pharmaceuticals, Ltd.
- Ticker KNSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,470,400
- Market Cap $658M
- Description
- Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...